<rss xmlns:cm="http://choicemedia.com/content/1.0" version="2.0"><channel><title>MultipleSclerosisCentral.com - Latest Multiple Sclerosis News</title><link>http://www.healthcentral.com/multiple-sclerosis/</link><description>Latest Multiple Sclerosis News from MultipleSclerosisCentral.com</description><language>en-us</language><ttl>60</ttl><image><title>MultipleSclerosisCentral.com</title><width>120</width><height>19</height><url>http://www.healthcentral.com/images/hc_logo_sm.gif</url><link>http://www.healthcentral.com/multiple-sclerosis/</link></image><item><pubDate>Mon, 16 Nov 2009 11:23:03 EST</pubDate><title>Divorce rate is higher when women get sick</title><link>http://www.healthcentral.com/multiple-sclerosis/news-417037-98.html</link><description>Women who receive a cancer or MS diagnosis are six times more likely to end up separated or divorced than a male spouse who receives the same diagnosis, a new study has found.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-417037-98.html</guid></item><item><pubDate>Mon, 16 Nov 2009 10:59:04 EST</pubDate><title>Mayo Clinic neurologist says many MS patients misdiagnosed</title><link>http://www.healthcentral.com/multiple-sclerosis/news-417022-98.html</link><description>According to Mayo Clinic neurologist Sean Pittock, thousands of people with Neuromyelitis Optica (NMO) are being misdiagnosed with multiple sclerosis.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-417022-98.html</guid></item><item><pubDate>Mon, 16 Nov 2009 10:44:03 EST</pubDate><title>Obese teens more prone to MS: study</title><link>http://www.healthcentral.com/multiple-sclerosis/news-417018-98.html</link><description>The study, published in the journal Neurology, found that girls who were obese at age 18 were twice as likely to develop MS later in life.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-417018-98.html</guid></item><item><pubDate>Sun, 15 Nov 2009 19:46:01 EST</pubDate><title>What to expect for Medicare Part D open enrollment</title><link>http://www.healthcentral.com/alzheimers/news-416821-98.html</link><description>An analysis by the Henry J. Kaiser Family Foundation has found that monthly premiums will rise an average 11 percent, though the premium changes vary widely by which plan seniors select.</description><guid isPermaLink="true">http://www.healthcentral.com/alzheimers/news-416821-98.html</guid></item><item><pubDate>Sun, 15 Nov 2009 19:24:04 EST</pubDate><title>Yahoo, Google want more leeway for drug advertising</title><link>http://www.healthcentral.com/alzheimers/news-416816-98.html</link><description>Drugmakers say the current FDA guidelines requiring both benefits and risks of drugs on ads hampers advertising on the Internet given the space constraints for ads on Web pages.</description><guid isPermaLink="true">http://www.healthcentral.com/alzheimers/news-416816-98.html</guid></item><item><pubDate>Thu, 12 Nov 2009 10:30:05 EST</pubDate><title>Acceptance of chronic illness helps people 'move on'</title><link>http://www.healthcentral.com/rheumatoid-arthritis/news-415718-98.html</link><description>According to new research, chronically ill patients who give up hope that they will get better are actually happier than people who have not accepted their condition.</description><guid isPermaLink="true">http://www.healthcentral.com/rheumatoid-arthritis/news-415718-98.html</guid></item><item><pubDate>Sun, 08 Nov 2009 18:31:01 EST</pubDate><title>House passes healthcare reform bill</title><link>http://www.healthcentral.com/alzheimers/news-414363-98.html</link><description>The U.S. House of Representatives passed a landmark healthcare reform after a 14-hour day of debate, with only one Republican backing the measure along with 219 Democrats.</description><guid isPermaLink="true">http://www.healthcentral.com/alzheimers/news-414363-98.html</guid></item><item><pubDate>Mon, 19 Oct 2009 21:49:03 EDT</pubDate><title>FDA panel backs MS drug</title><link>http://www.healthcentral.com/multiple-sclerosis/news-407949-98.html</link><description>A U.S. Food and Drug Administration (FDA) panel has recommended approval of the MS drug fampridine.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-407949-98.html</guid></item><item><pubDate>Mon, 05 Oct 2009 13:21:01 EDT</pubDate><title>Drugmaker says its MS drug reduces relapses</title><link>http://www.healthcentral.com/multiple-sclerosis/news-404402-98.html</link><description>According to drugmaker Novartis, their experimental MS drug FTY720 reduces relapses and disability progression.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-404402-98.html</guid></item><item><pubDate>Tue, 29 Sep 2009 17:02:00 EDT</pubDate><title>Senate Finance Committee rejects public healthcare option</title><link>http://www.healthcentral.com/alzheimers/news-402965-98.html</link><description>Five Democrats voted with all of the panel's Republicans in opposing the inclusion of the government-run option in the bill in what is expected to be the first of several battles in Congress over the public option.</description><guid isPermaLink="true">http://www.healthcentral.com/alzheimers/news-402965-98.html</guid></item><item><pubDate>Mon, 21 Sep 2009 13:14:03 EDT</pubDate><title>Experimental MS drug may reduce relapses</title><link>http://www.healthcentral.com/multiple-sclerosis/news-376669-98.html</link><description>Drugmaker Opexa says their experimental drug Tovaxin helped 83 percent of patients with relapsing remitting multiple sclerosis remain relapse free after a year.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-376669-98.html</guid></item><item><pubDate>Mon, 21 Sep 2009 13:07:02 EDT</pubDate><title>FDA updates Tysabri safety information</title><link>http://www.healthcentral.com/multiple-sclerosis/news-376664-98.html</link><description>The new information warns patients that the risk of progressive multifocal leukoencephalopathy, or PML, appears to increase as the number of Tysabri infusions increase.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-376664-98.html</guid></item><item><pubDate>Sun, 13 Sep 2009 16:47:00 EDT</pubDate><title>New RA drug stalls in mid-stage trials</title><link>http://www.healthcentral.com/rheumatoid-arthritis/news-304652-98.html</link><description>A new drug called atacicept that is being developed to treat rheumatoid arthritis has failed to meet its goals in mid-stage clinical trials, its maker reports.</description><guid isPermaLink="true">http://www.healthcentral.com/rheumatoid-arthritis/news-304652-98.html</guid></item><item><pubDate>Tue, 08 Sep 2009 10:00:02 EDT</pubDate><title>Figuring out your medical bills</title><link>http://www.healthcentral.com/rheumatoid-arthritis/news-304401-98.html</link><description>A reporter discusses the best ways to navigate the sea of medical-billing red tape.</description><guid isPermaLink="true">http://www.healthcentral.com/rheumatoid-arthritis/news-304401-98.html</guid></item><item><pubDate>Mon, 31 Aug 2009 13:02:00 EDT</pubDate><title>Blood pressure drug may work against MS</title><link>http://www.healthcentral.com/multiple-sclerosis/news-296436-98.html</link><description>Research shows inflammation link between two disorders.</description><guid isPermaLink="true">http://www.healthcentral.com/multiple-sclerosis/news-296436-98.html</guid></item></channel></rss>